Driehaus Capital Management’s Core Laboratories CLB Stock Holding History

Driehaus Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-118,795	Closed	-$4.63M	–	403
2021 Q2	$4.63M	Buy	+118,795	New	+$4.26M	0.06%	278
2018 Q3	–	Sell	-243,697	Closed	-$30.8M	–	469
2018 Q2	$30.8M	Buy	+243,697	New	+$29.7M	1.04%	13
2016 Q3	–	Sell	-5,369	Closed	-$665K	–	521
2016 Q2	$665K	Sell	5,369 -2	-0%	-$241	0.02%	395
2016 Q1	$604K	Sell	5,371 -59	-1%	-$6.13K	0.02%	436
2015 Q4	$590K	Buy	+5,430	New	+$622K	0.02%	444
2013 Q3	–	Sell	-15,603	Closed	-$2.37M	–	453
2013 Q2	$2.37M	Buy	+15,603	New	+$2.21M	0.1%	242

Other funds holding CLB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Driehaus Capital Management's CLB Position: Q3 2021 in Review

Driehaus Capital Management sold out of Core Laboratories (CLB) in Q3 2021, closing a stake of 118,795 shares — an estimated $4.63M sold.

Driehaus Capital Management first reported a position in CLB in Q2 2013 and held it in 6 quarters. The position peaked at $30.8M in Q2 2018. 198 funds tracked by Wall St. Rank hold CLB as of Q3 2021.

Driehaus Capital Management reported no remaining Core Laboratories position as of Q3 2021 after selling out during the quarter.
Driehaus Capital Management sold 118,795 Core Laboratories shares in Q3 2021, an estimated $4.63M.
Driehaus Capital Management first reported a position in Core Laboratories in Q2 2013 and held it in 6 quarters.
Driehaus Capital Management's Core Laboratories position peaked at $30.8M in Q2 2018.
198 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2021.

Based on Driehaus Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.